Groff North America
PrivateLast Round
Series B
Oct 31, 2023
Total Funding Raised
$7.5M
Company Overview
Groff North America operates in Healthcare & Life Sciences and is based in Red Lion, Pennsylvania. Its latest recorded funding round was an Early Funding round in November 2019.
Groff North America is a biotechnology company that specializes in the research, development, and manufacturing of pharmaceutical-grade cannabis and hemp-based therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Compliance
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Groff North America Comparables
Compare Groff North America with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Royal Emerald Pharmaceuticals | 88% | |
| Irvine Labs, Inc. | 86% | |
| BRC Bio | 85% |
For institutional investors. Book with your work email.
Groff North America Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 31, 2023 | ||||
| Growth Equity | Jul 17, 2023 | ||||
| Early Funding | Nov 14, 2019 |
For institutional investors. Book with your work email.
Groff North America Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kinsley Enterprises | Early Funding, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 83% MoM.
- Oct 31, 2023
Led by Kinsley Enterprises
For institutional investors. Book with your work email.
Groff North America Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Groff North America's valuation, stock price, and market status.
Is Groff North America a public or private company?
Groff North America is a private company.
What is the current stock price of Groff North America?
Groff North America is a private company, so its shares have no public market price. Caplight tracks Groff North America's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Groff North America worth (valuation)?
Valuation information for Groff North America is not publicly available.
Can I buy Groff North America stock?
Groff North America shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Groff North America's last funding round?
Groff North America's most recent funding round was Series B on October 31, 2023.
Who are the main investors in Groff North America?
Key investors in Groff North America include Kinsley Enterprises.
Will Groff North America IPO soon?
No public IPO plans have been announced for Groff North America.
How can I track Groff North America secondary market activity?
Caplight tracks bids, offers, and trades in Groff North America's shares on secondary markets.